[HTML][HTML] A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer
Q Zhao, K Sun, X Lei, L Cai - Medicine, 2020 - journals.lww.com
Background: Whether the combination of gefitinib and chemotherapy is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to
summarize the currently available evidence and compare the efficacy and safety of gefitinib
combined with chemotherapy versus chemotherapy alone for treating advanced NSCLC.
Methods: Literature on comparing the effects of gefitinib combined with chemotherapy and
chemotherapy alone in treating NSCLC was retrieved from the PubMed, EMBASE and …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to
summarize the currently available evidence and compare the efficacy and safety of gefitinib
combined with chemotherapy versus chemotherapy alone for treating advanced NSCLC.
Methods: Literature on comparing the effects of gefitinib combined with chemotherapy and
chemotherapy alone in treating NSCLC was retrieved from the PubMed, EMBASE and …
以上显示的是最相近的搜索结果。 查看全部搜索结果